The Short Version
No available evidence supports this highly specific claim. The only 2025 study linked to Babol University of Medical Sciences in the evidence record used the GHQ-12 instrument — not the DASS-21 — and reported no 64.6% depressive-symptom prevalence. The most rigorous meta-analytic data on Iranian medical students estimates overall depression prevalence at approximately 43%, making the claimed figure a significant outlier with no identifiable source.